Parameters | IM group (n = 104) | Non-IM group (n = 50) | P |
---|---|---|---|
Sex (male) | 47 (45.2) | 27 (54.0) | 0.306 |
Age (years) | 2.9 (1.9–4.1) | 3.2 (2.2–5.1) | 0.207 |
Disease course (days) | 3.0 (3.0–4.0) | 3.0 (2.8-4.0) | 0.263 |
WBC (×109/L) | 16.4 (12.3–21.0) | 13.7 (9.3–19.3) | 0.049 |
Lymphocyte count(×109/L) | 10.6 (7.0–14.0) | 3.4 (2.3–5.2) | < 0.001 |
ADA (U/L) | 51.6 (44.5–66.5) | 20.1 (17.1–23.8) | < 0.001 |
IgA (g/L) | 1.4 (1.0–1.9) | 0.8 (0.5–1.2) | < 0.001 |
IgG (g/L) | 11.3 ± 2.8 | 7.7 ± 2.2 | < 0.001 |
IgM (g/L) | 1.6 (1.3–2.2) | 1.1 (0.8–1.6) | < 0.001 |
CD3+ (%) | 79.1 (72.6–82.8) | 63.8 (54.1–71.8) | < 0.001 |
CD3 + CD4+ (%) | 17.6 (13.3–21.7) | 32.1 (24.8–39.2) | < 0.001 |
CD3 + CD8+ (%) | 53.9 ± 11.0 | 25.0 ± 8.0 | < 0.001 |
CD4+/CD8+ | 0.3 (0.2-0.475) | 1.2 (1.0-1.7) | < 0.001 |
CD3-CD (16 + 56) + (%) | 11.9 (8.1–16.9) | 11.1 (6.7–16.1) | 0.616 |
CD3-CD19+ (%) | 7.8 (5.2–9.8) | 20.9 (16.0–29.8) | < 0.001 |
CD19 + CD23+ (%) | 4.0 (2.4–6.3) | 9.9 (6.8–12.7) | < 0.001 |